Literature DB >> 33145740

18F-FDG PET/CMR in cardiac sarcoidosis: A wild card in the deck?

Carmela Nappi1, Andrea Ponsiglione1, Massimo Imbriaco1, Alberto Cuocolo2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33145740     DOI： 10.1007/s12350-020-02427-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  7 in total

1.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

2.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

Authors:  Jan-Peter Smedema; Gabriel Snoep; Marinus P G van Kroonenburgh; Robert-Jan van Geuns; Willem R M Dassen; Anton P M Gorgels; Harry J G M Crijns
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

3.  Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography/cardiac magnetic resonance imaging in cardiac sarcoidosis.

Authors:  Mana Okune; Masakazu Yasuda; Naoko Soejima; Yoshinori Kagioka; Kazuyoshi Kakehi; Takayuki Kawamura; Kohei Hanaoka; Hayato Kaida; Kazunari Ishii; Gaku Nakazawa; Shunichi Miyazaki; Yoshitaka Iwanaga
Journal:  J Nucl Cardiol       Date:  2020-10-01       Impact factor: 5.952

Review 4.  Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.

Authors:  G Cameron Coleman; Peter W Shaw; Pelbreton C Balfour; Jorge A Gonzalez; Christopher M Kramer; Amit R Patel; Michael Salerno
Journal:  JACC Cardiovasc Imaging       Date:  2016-07-20

5.  Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis.

Authors:  Rumman Langah; Kenneth Spicer; Mulugeta Gebregziabher; Leonie Gordon
Journal:  J Nucl Cardiol       Date:  2009-06-23       Impact factor: 5.952

6.  What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers?

Authors:  Sang-Geon Cho; Hyung Yoon Kim; Hee-Seung Bom
Journal:  J Nucl Cardiol       Date:  2019-11-25       Impact factor: 5.952

7.  Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.

Authors:  Marc R Dweck; Ronan Abgral; Maria Giovanna Trivieri; Philip M Robson; Nicolas Karakatsanis; Venkatesh Mani; Anna Palmisano; Marc A Miller; Anuradha Lala; Helena L Chang; Javier Sanz; Johanna Contreras; Jagat Narula; Valentin Fuster; Maria Padilla; Zahi A Fayad; Jason C Kovacic
Journal:  JACC Cardiovasc Imaging       Date:  2017-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.